Valbiotis S.A.
ALVAL.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €23,920 | €14,954 | €62,500 |
| - Cash | – | €11,580 | €18,545 | €25,017 |
| + Debt | – | €5,719 | €6,103 | €6,880 |
| Enterprise Value | – | €18,059 | €2,512 | €44,363 |
| Revenue | €332 | €140 | €35 | -€503 |
| % Growth | 137.1% | 300% | 107% | – |
| Gross Profit | -€634 | -€1,425 | -€925 | -€1,570 |
| % Margin | -191% | -1,017.9% | -2,642.9% | 312.1% |
| EBITDA | -€4,611 | -€6,332 | -€2,840 | -€4,750 |
| % Margin | -1,388.9% | -4,522.9% | -8,114.3% | 944.3% |
| Net Income | -€4,593 | -€6,522 | -€3,503 | -€5,440 |
| % Margin | -1,383.4% | -4,658.6% | -10,008.6% | 1,081.5% |
| EPS Diluted | 0 | -0.41 | -0.28 | -0.44 |
| % Growth | 100% | -46.4% | 36.4% | – |
| Operating Cash Flow | -€3,916 | -€5,789 | -€5,748 | -€1,667 |
| Capital Expenditures | €0 | -€131 | -€16 | -€14 |
| Free Cash Flow | -€3,916 | -€5,920 | -€5,764 | -€1,681 |